Mostrar el registro sencillo del ítem

Guselkumab and il-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis: 6-month interim results of the psabiond observational cohort study

dc.contributor.authorGossec, Laure
dc.contributor.authorSharaf, Mohamed
dc.contributor.authorBaraliakos, Xenofon
dc.contributor.authorKishimoto, Mitsumasa
dc.contributor.authorLubrano, Ennio
dc.contributor.authorRahman, Proton
dc.contributor.authorRampakakis, Emmanouil
dc.contributor.authorKoleseri, Laszlo
dc.contributor.authorKoivunen, Minni
dc.contributor.authorLavie, Frederic
dc.contributor.authorSoriano, Enrique R.
dc.contributor.authorQueiro Silva, Rubén 
dc.contributor.authorBehrens, Frank
dc.contributor.authorSiebert, Stefan
dc.date.accessioned2025-04-30T09:20:16Z
dc.date.available2025-04-30T09:20:16Z
dc.date.issued2024
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/10651/78742
dc.format.extentp. 2973-2976
dc.language.isoeng
dc.relation.ispartofArthritis & Rheumatology
dc.rights©,
dc.sourceWOS:001331419104200
dc.titleGuselkumab and il-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis: 6-month interim results of the psabiond observational cohort study
dc.typeconference output


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem